Archive · 2 Jun 2025
Wockhardt Q4 Results: Loss Narrows, Revenue Increases
Imagine a company called Wockhardt that makes medicines.
They had a tough time last year, losing a lot of money.
But, things are getting better!
In the latest three months, they lost much less money, almost four times less than before.
They also made more money overall, about 6% more than last year.
They controlled their costs better, which helped them.
The company also announced that a director will stay on for another five years, if the shareholders agree.
This is a good sign for the company's future.
Wockhardt's net loss narrowed to ₹45 crore in Q4 FY25, from ₹177 crore in Q4 FY24.
Revenue for Q4 FY25 increased by 6% year-on-year to ₹743 crore.
The company reported an EBITDA of ₹64 crore, improving from an EBITDA loss of ₹103 crore in the prior year's quarter.
Akhilesh Krishna Gupta was re-appointed as an Independent Director for a five-year term, subject to shareholder approval.
Wockhardt shares closed at ₹1,347.75 on the BSE, up 0.63%.
- Who
- Wockhardt Ltd
- What
- Reported a narrowed net loss and increased revenue for Q4 FY25
- When
- For the quarter ended March 2025
- Where
- BSE
- Why
- Due to revenue growth and improved operational performance.
Market Performance
Stakeholder Approval
Financial Performance
Market Performance
There are no opposing viewpoints regarding the reported financial performance.
Stakeholder Approval
Company experienced growth in revenue and an improved financial position with a narrowed loss and a return to positive EBITDA, indicating better cost control and market performance.
- Net Loss Q4 FY25
- ₹45 crore
- Net Loss Q4 FY24
- ₹177 crore
- Revenue Q4 FY25
- ₹743 crore
- Revenue Q4 FY24
- ₹700 crore
- EBITDA Q4 FY25
- ₹64 crore
- EBITDA Loss Q4 FY24
- ₹103 crore
- Independent Director Re-appointment
- Akhilesh Krishna Gupta
- New Term Start
- August 29, 2025
- New Term End
- August 28, 2030
- Wockhardt Share Price
- ₹1,347.75